母婴分泌型状态影响孟加拉国母乳喂养婴儿口服轮状病毒疫苗的反应。
Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.
机构信息
The University of Vermont Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
出版信息
J Infect Dis. 2021 Oct 13;224(7):1147-1151. doi: 10.1093/infdis/jiaa101.
Abstract
Secretor status controls mucosal histo-blood group antigen expression and is associated with susceptibility to rotavirus (RV) diarrhea, with nonsecretors less susceptible to symptomatic infection. The role of breast milk secretor status on oral live-attenuated RV vaccine response in breastfed infants has not been explored. In a monovalent G1P[8] RV vaccine (Rotarix) trial in Bangladesh, RV-specific plasma immunoglobulin A antibody seroconversion rates were higher among infants of maternal nonsecretors (39%) than infants of maternal secretors (23%; P = .001). Maternal status remained a significant predictor when correcting for infant status (P = .002). Maternal secretor status should be considered when interpreting oral RV vaccine responses in low- and middle-income settings. Clinical Trials Registration. NCT01375647.
摘要
分泌状态控制黏膜组织血型抗原的表达，并与轮状病毒（RV）腹泻的易感性相关，非分泌者症状感染的易感性较低。母乳分泌状态对母乳喂养婴儿口服减毒 RV 疫苗反应的影响尚未得到探索。在孟加拉国进行的单价 G1P[8]RV 疫苗（Rotarix）试验中，母亲为非分泌者的婴儿（39%）RV 特异性血浆免疫球蛋白 A 抗体血清转化率高于母亲为分泌者的婴儿（23%；P =.001）。当校正婴儿状态时，母亲状态仍然是一个显著的预测因素（P =.002）。在解释低收入和中等收入国家口服 RV 疫苗反应时，应考虑母体分泌状态。临床试验注册。NCT01375647。
相似文献
1
Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.
J Infect Dis. 2021 Oct 13;224(7):1147-1151. doi: 10.1093/infdis/jiaa101.
2
Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
J Infect Dis. 2018 Apr 11;217(9):1399-1407. doi: 10.1093/infdis/jiy054.
3
Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
Clin Infect Dis. 2018 Jul 2;67(2):186-192. doi: 10.1093/cid/ciy076.
4
Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
J Infect Dis. 2019 Feb 15;219(5):746-749. doi: 10.1093/infdis/jiy573.
5
Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
Clin Infect Dis. 2016 Jan 15;62(2):157-65. doi: 10.1093/cid/civ828. Epub 2015 Sep 23.
6
Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
PLoS One. 2016 Mar 14;11(3):e0150100. doi: 10.1371/journal.pone.0150100. eCollection 2016.
7
Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
Vaccine. 2014 Aug 11;32 Suppl 1:A134-9. doi: 10.1016/j.vaccine.2014.04.078.
8
The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
Vaccine. 2020 Jan 3;38(1):90-99. doi: 10.1016/j.vaccine.2019.09.088. Epub 2019 Oct 10.
9
Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.
Viruses. 2021 Jun 14;13(6):1144. doi: 10.3390/v13061144.
10
Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants.
J Infect Dis. 2017 Mar 1;215(5):786-789. doi: 10.1093/infdis/jix028.
引用本文的文献
1
Geographic disparities impacting oral vaccine performance: Observations and future directions.
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae124.
2
Associations Between Histo-blood Group Antigen Status in Mother-Infant Dyads and Infant Oral Rotavirus Vaccine Immunogenicity in Rural Zimbabwe.
J Infect Dis. 2025 Feb 4;231(1):e225-e233. doi: 10.1093/infdis/jiae456.
3
Infant Non-Secretor Histoblood Group Antigen Phenotype Reduces Susceptibility to Both Symptomatic and Asymptomatic Rotavirus Infection.
Pathogens. 2024 Mar 4;13(3):223. doi: 10.3390/pathogens13030223.
4
Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants.
J Infect Dis. 2024 Sep 23;230(3):754-762. doi: 10.1093/infdis/jiae055.
5
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix) Immunogenicity among Infants in Zambia.
Vaccines (Basel). 2023 Jul 31;11(8):1303. doi: 10.3390/vaccines11081303.
6
Maternal Breast Milk Secretor Phenotype Does Not Affect Infant Susceptibility to Rotavirus Diarrhea.
Open Forum Infect Dis. 2023 Jun 7;10(6):ofad299. doi: 10.1093/ofid/ofad299. eCollection 2023 Jun.
7
Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
Lancet Infect Dis. 2022 Nov;22(11):1606-1616. doi: 10.1016/S1473-3099(22)00368-1. Epub 2022 Aug 9.
8
Controlled Human Infection Models To Accelerate Vaccine Development.
Clin Microbiol Rev. 2022 Sep 21;35(3):e0000821. doi: 10.1128/cmr.00008-21. Epub 2022 Jul 6.
9
Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD008521. doi: 10.1002/14651858.CD008521.pub6.
10
Global Experience With Rotavirus Vaccines.
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S792-S800. doi: 10.1093/infdis/jiab399.
本文引用的文献
1
Effects of Child and Maternal Histo-Blood Group Antigen Status on Symptomatic and Asymptomatic Enteric Infections in Early Childhood.
J Infect Dis. 2019 Jun 5;220(1):151-162. doi: 10.1093/infdis/jiz072.
2
Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.
Clin Infect Dis. 2019 Sep 27;69(8):1313-1319. doi: 10.1093/cid/ciy1067.
3
Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
J Infect Dis. 2019 Feb 15;219(5):746-749. doi: 10.1093/infdis/jiy573.
4
Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
Clin Infect Dis. 2018 Jul 2;67(2):186-192. doi: 10.1093/cid/ciy076.
5
Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
J Infect Dis. 2018 Apr 11;217(9):1399-1407. doi: 10.1093/infdis/jiy054.
6
Causes of impaired oral vaccine efficacy in developing countries.
Future Microbiol. 2018 Jan;13(1):97-118. doi: 10.2217/fmb-2017-0128. Epub 2017 Dec 8.
7
Milk Oligosaccharides Inhibit Human Rotavirus Infectivity in MA104 Cells.
J Nutr. 2017 Sep;147(9):1709-1714. doi: 10.3945/jn.116.246090. Epub 2017 Jun 21.
8
Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants.
J Infect Dis. 2017 Mar 1;215(5):786-789. doi: 10.1093/infdis/jix028.
9
Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial.
Clin Infect Dis. 2016 Sep 1;63(5):634-41. doi: 10.1093/cid/ciw346. Epub 2016 May 23.
10
Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.
Clin Infect Dis. 2016 May 1;62 Suppl 2(Suppl 2):S96-S105. doi: 10.1093/cid/civ1013.
Zotero 插件